Psychiatric disorder and accelerated aging: The Dunedin Multidisciplinary Health and Development Longitudinal Cohort Study

精神疾病和加速衰老:达尼丁多学科健康与发展纵向队列研究

基本信息

  • 批准号:
    MR/K00381X/1
  • 负责人:
  • 金额:
    $ 131.55万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2013
  • 资助国家:
    英国
  • 起止时间:
    2013 至 无数据
  • 项目状态:
    已结题

项目摘要

BACKGROUND: We propose to test the novel hypothesis that a persistent history of psychiatric disorder might accelerate individuals' risk of progression toward age-related disease. Specifically, the hypothesis is that people who suffer chronic or recurrent psychiatric disorders during early adulthood will, already by their late thirties, show cognitive decline and abnormal status on sub-clinical biomarkers that are known to be prognostic early warning signs for late-life diseases, frailty and disability. Rather than focus on psychiatric disorders as the outcome, here we propose to study psychiatric disorders as a potentially preventable 'exposure' that may accelerate aging.METHOD: We will test this hypothesis in the context of the Dunedin Study, a longitudinal study from birth to age 38 of a representative birth cohort of New Zealand men and women (N=1037) with over 90% cohort retention. A unique design feature is that baseline physical health and baseline neuropsychological assessments were carried out from birth to age 13, prior to the onset of most psychiatric disorders. To our knowledge, no other study of the health consequences of psychiatric disorder has these prospective baseline data, which are essential to test whether health and neuropsychological functions have actually deteriorated in individuals who have experienced persistent psychiatric disorder. Cohort members' psychiatric histories of recurrent Depression, recurrent Anxiety, chronic Schizophrenia-syndrome, persistent Alcohol Dependence, and persistent Cannabis Dependence will be defined using data from repeated assessments across 25 intervening years in this longitudinal study. With MRC funding, we most recently assessed the cohort again at age 38. We assessed sensitive outcome measures of sub-clinical health status that are known predictors of age-related diseases in later life: neuropsychological tests of memory and executive functions, the metabolic syndrome, inflammation biomarkers, retinal micro-vasculature, and shortened telomere length. These markers were chosen because they are known early warning signs for dementia, cardiovascular disease and diabetes. The markers show meaningful variation among people in their late 30's, and the Dunedin study has sufficient numbers of cases to test whether recurrent psychiatric disorder predicts health outcomes, while controlling for baseline health status in childhood. INNOVATION AND SIGNIFICANCE: Life expectancy is growing longer and longer. Policy makers and citizens are concerned that our extra years of life should be healthy, productive, and enjoyable, not extra years of disease and disability. The hope of preventing age-related diseases and of increasing health expectancy requires research to identify candidate risk targets that can be treated successfully, in early-to-middle adulthood. If the hypothesis that psychiatric disorder accelerates the sub-clinical progression toward age-related disease were shown to be true by our proposed research, this would imply that age-related disease could be reduced by successfully treating psychiatric disorders early in life.
背景:我们提出检验一种新的假设,即持续的精神疾病史可能会加速个体向年龄相关疾病发展的风险。具体来说,该假设是,在成年早期患有慢性或复发性精神疾病的人,在30多岁之前,就会表现出认知能力下降和亚临床生物标志物的异常状态,这些生物标志物已知是晚年疾病、虚弱和残疾的预后预警信号。与其将精神疾病作为结果来关注,我们建议将精神疾病作为可能加速衰老的潜在可预防的“暴露”来研究。方法:我们将在达尼丁研究的背景下检验这一假设,达尼丁研究是一项从出生到38岁的纵向研究,研究对象为新西兰男性和女性的代表性出生队列(N=1037),队列保留率超过90%。一个独特的设计特点是,在大多数精神疾病发作之前,从出生到13岁进行基线身体健康和基线神经心理学评估。据我们所知,没有其他关于精神障碍健康后果的研究有这些前瞻性基线数据,这些数据对于测试患有持续性精神障碍的个体的健康和神经心理功能是否真的恶化至关重要。队列成员的复发性抑郁、复发性焦虑、慢性精神分裂症综合征、持续酒精依赖和持续大麻依赖的精神病史将在这项纵向研究中使用25年重复评估的数据来定义。在MRC的资助下,我们最近再次对38岁的队列进行了评估。我们评估了亚临床健康状态的敏感结果指标,这些指标已知是晚年年龄相关疾病的预测指标:记忆和执行功能的神经心理测试、代谢综合征、炎症生物标志物、视网膜微血管和缩短的端粒长度。之所以选择这些标志物,是因为它们是已知的痴呆症、心血管疾病和糖尿病的早期预警信号。这些指标在接近40岁的人群中显示出有意义的差异,达尼丁的研究有足够数量的病例来测试复发性精神疾病是否能预测健康结果,同时控制儿童时期的基线健康状况。创新与意义:人们的预期寿命越来越长。政策制定者和公民关心的是,我们的额外寿命应该是健康的、富有成效的和愉快的,而不是疾病和残疾的额外寿命。为了预防与年龄有关的疾病和提高健康预期,需要进行研究,以确定在成年早期至中期可以成功治疗的候选风险目标。如果我们提出的研究证明精神障碍加速年龄相关疾病的亚临床进展的假设是正确的,这将意味着通过在生命早期成功治疗精神障碍,可以减少年龄相关疾病。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Is Obesity Associated With a Decline in Intelligence Quotient During the First Half of the Life Course?
  • DOI:
    10.1093/aje/kwt135
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Belsky, Daniel W.;Caspi, Avshalom;Moffitt, Terrie E.
  • 通讯作者:
    Moffitt, Terrie E.
Is Chronic Asthma Associated with Shorter Leukocyte Telomere Length at Midlife?
The potential to predict the course of childhood asthma.
Adult-onset offenders: Is a tailored theory warranted?
  • DOI:
    10.1016/j.jcrimjus.2016.03.001
  • 发表时间:
    2016-09-01
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Beckley AL;Caspi A;Harrington H;Houts RM;Mcgee TR;Morgan N;Schroeder F;Ramrakha S;Poulton R;Moffitt TE
  • 通讯作者:
    Moffitt TE
Cardiorespiratory fitness and cognitive function in midlife: neuroprotection or neuroselection?
  • DOI:
    10.1002/ana.24356
  • 发表时间:
    2015-04
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Belsky, Daniel W.;Caspi, Avshalom;Israel, Salomon;Blumenthal, James A.;Poulton, Richie;Moffitt, Terrie E.
  • 通讯作者:
    Moffitt, Terrie E.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Terrie Moffitt其他文献

7.1 Is Adult Attention-Deficit/Hyperactivity Disorder a Childhood-Onset Neurodevelopmental Disorder? Evidence from a Four-Decade Longitudinal Cohort Study
  • DOI:
    10.1016/j.jaac.2016.07.159
  • 发表时间:
    2016-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Terrie Moffitt
  • 通讯作者:
    Terrie Moffitt
11.1 CHILDHOOD EXPOSURE TO AMBIENT AIR POLLUTION AND THE RISK OF DEPRESSION IN ADOLESCENCE
  • DOI:
    10.1016/j.jaac.2020.08.165
  • 发表时间:
    2020-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Rachel M. Latham;Christian Kieling;Louise Arseneault;Thiago B.M. Rocha;Andrew Beddows;Sean D. Beevers;Kathryn De Oliveira;Terrie Moffitt;Aaron Reuben;Helen L. Fisher
  • 通讯作者:
    Helen L. Fisher
Cross-modality contrast: Exteroceptive context habituation enhances taste neophobia and conditioned taste aversions
  • DOI:
    10.3758/bf03197764
  • 发表时间:
    1980-12-01
  • 期刊:
  • 影响因子:
    1.500
  • 作者:
    Denis Mitchell;William Winter;Terrie Moffitt
  • 通讯作者:
    Terrie Moffitt

Terrie Moffitt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Terrie Moffitt', 18)}}的其他基金

Midlife Aging in the Dunedin Study Phase 52
但尼丁研究第 52 阶段的中年老龄化
  • 批准号:
    MR/X021149/1
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
    Research Grant
Midlife Pace of Aging in the Dunedin Study
但尼丁研究中的中年老龄化速度
  • 批准号:
    MR/P005918/1
  • 财政年份:
    2017
  • 资助金额:
    $ 131.55万
  • 项目类别:
    Research Grant
Generating new knowledge to support reversability interventions
生成新知识以支持可逆性干预措施
  • 批准号:
    ES/M010309/1
  • 财政年份:
    2015
  • 资助金额:
    $ 131.55万
  • 项目类别:
    Research Grant
Mental Disorders from Childhood to Adulthood: The Dunedin Study
从童年到成年的精神障碍:达尼丁研究
  • 批准号:
    G0601483/1
  • 财政年份:
    2007
  • 资助金额:
    $ 131.55万
  • 项目类别:
    Research Grant

相似国自然基金

基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
  • 批准号:
    82371607
  • 批准年份:
    2023
  • 资助金额:
    46.00 万元
  • 项目类别:
    面上项目
儿童音乐能力发展对语言与社会认知能力及脑发育的影响
  • 批准号:
    31971003
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
TGFβ1调控的谷氨酰胺代谢重编程在肾透明细胞癌中的功能及分子机制
  • 批准号:
    31960145
  • 批准年份:
    2019
  • 资助金额:
    40.0 万元
  • 项目类别:
    地区科学基金项目
双极性躁郁症(Bipolar Disorder)的人诱导多能干细胞模型的建立和神经病理研究
  • 批准号:
    31471020
  • 批准年份:
    2014
  • 资助金额:
    87.0 万元
  • 项目类别:
    面上项目
各向同性淬致无序环境中层列型液晶A-C相变
  • 批准号:
    11004241
  • 批准年份:
    2010
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
磁性隧道结的势垒及电极无序效应的研究
  • 批准号:
    10874076
  • 批准年份:
    2008
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目
表达BDNF-Ant(穿膜肽)融合蛋白的重组腺相关病毒(AAV)对慢性应激抑郁大鼠海马神经元保护作用的研究
  • 批准号:
    30870887
  • 批准年份:
    2008
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
表达神经保护肽(NAP和SAL)的重组腺相关病毒对慢性应激抑郁大鼠海马神经元保护作用的研究
  • 批准号:
    30700261
  • 批准年份:
    2007
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
  • 批准号:
    10726660
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Targeted Neuroplasticity via vagus nerve stimulation to improve urinary dysfunction after spinal cord injury
通过迷走神经刺激的靶向神经可塑性改善脊髓损伤后的泌尿功能障碍
  • 批准号:
    10785466
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Barriers to Healthcare and Cardiovascular Risk Influences on Accelerated Brain Aging and Disability in Hispanic Persons with Multiple Sclerosis
医疗保健障碍和心血管风险对西班牙裔多发性硬化症患者大脑加速老化和残疾的影响
  • 批准号:
    10785537
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Molecular mechanisms of aging and accelerated aging in the human brain
人脑衰老和加速衰老的分子机制
  • 批准号:
    10713873
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome
Hutchinson-Gilford 早衰综合症中 DNA 甲基化的加速改变
  • 批准号:
    10780718
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Accelerated Cerebrovascular Aging in a Fibrillin-1 Mutated Mouse Model
Fibrillin-1 突变小鼠模型加速脑血管老化
  • 批准号:
    10727231
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Accelerated Resolution Therapy for Early Maladaptive Grief: A Clinical Trial
早期适应不良悲伤的加速解决疗法:临床试验
  • 批准号:
    10578937
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Suicide Circuit Therapeutics: Engaging Novel Targets with Rapid and Individualized MRI-Guided Accelerated TMS
自杀回路治疗:通过快速、个性化的 MRI 引导加速 TMS 参与新靶点
  • 批准号:
    10646517
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Posttraumatic Stress Disorder, Accelerated Biological Aging, and Veteran Health
创伤后应激障碍、加速生物衰老和退伍军人健康
  • 批准号:
    10705915
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
解决子宫内膜异位症女性心血管疾病风险加速的机制和干预措施
  • 批准号:
    10838754
  • 财政年份:
    2023
  • 资助金额:
    $ 131.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了